Filter
191
Text search:
dolutegravir
Featured
Recommendations
21
New Publications
40
Language
Document type
No document type
77
Guidelines
48
Studies & Reports
35
Manuals
9
Strategic & Response Plan
7
Fact sheets
6
Training Material
4
Situation Updates
2
Infographics
2
Countries / Regions
South Africa
9
Argentina
7
Global
6
Malawi
5
Namibia
4
Latin America and the Carribbean
4
Kenya
3
Africa
3
Uganda
2
Brazil
2
Botswana
2
Myanmar / Burma
2
South–East Asia Region
2
Guinea
1
Nigeria
1
Congo, Democratic Republic of
1
Ethiopia
1
Zimbabwe
1
Philippines
1
India
1
Somalia
1
Nepal
1
Zambia
1
Thailand
1
Rwanda
1
Mozambique
1
Central African Republic
1
Peru
1
Ukraine
1
Colombia
1
Bolivia
1
Lesotho
1
Chile
1
Western Pacific Region
1
Western and Central Europe
1
Venezuela
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
45
Clinical Guidelines
25
Women & Child Health
4
Pharmacy & Technologies
2
Public Health
1
Key Resources
1
Toolboxes
HIV
127
TB
11
Pharmacy
8
AMR
4
COVID-19
3
NTDs
3
Conflict
2
Refugee
2
Mental Health
2
Malaria
1
Accessed on 20.08.2022
Antirretrovirales de uso general
Antirretrovirales de uso en pacientes con múltiples fracasos terapéuticos
No antirretrovirales de uso general
No antirretrovirales de uso nominal
Medicación para tratamiento de tuberculosis p.línea
Medicación para tratamiento d
...
The Panel recommendations on initial combination regimens for the antiretroviral therapy (ART)-naive, HIV-infected patients.
6th edition. The HIV epidemic Namibia is gradually being brouhgt under countrol as demonstrated by results in the preliminary report of Namibia Population-Based HIV Impact Assessment (NAMPHIA), a cross-sectional household-based survey that was conducted in 2017. Currently, it is estimated that about
...
Program Considerations
Topics in Antiviral Medicine, March 4, 2025
En la presente publicación se formulan orientaciones sobre la respuesta de salud pública a la farmacorresistencia del VIH (FRVIH) a inhibidores no nucleosídicos de la retrotranscriptasa (INNRT), previa al tratamiento, en personas con exposición previa a los fármacos antirretrovirales (ARV) o si
...
International Journal of Infectious Diseases 70 (2018) 121–130
https://doi.org/10.1016/j.ijid.2018.03.007
1201-9712/© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://cr
...
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
The checklist and reference list has two parts: high-level cross-cutting content (Part A) and specific programme content (Part B). Part A applies to all countries and contains situation and response analysis, the NSP development process, the goal, targets and priority-setting of the NSP and the prin
...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
